S. 127, the Pharmacy Benefit Manager Transparency Act of 2023, would increase drug pricing transparency for employers and plan sponsors
Editor's note · Context
Cantwell discusses legislation aimed at enhancing transparency in drug pricing.
Share
More from Maria Cantwell
The next couple of days will be challenging, but we are going to do everything we can to make sure the resources are here and continue to make sure that this issue gets our nation's attention.
I’m glad Senator Thune set a date certain in September to bring it up because the challenges facing student athletes and universities aren’t going away.
But despite these advancements, we've seen 14,000 young people remain unstably housed or homeless, which makes this development project so much more important.
There are some up here with us who have been evacuated. There are some that have lost their homes. So we are with you in this situation, and we're going to do everything we can to get the federal resources to help you.





